# OnCo record delta-fly-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/delta-fly-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "delta-fly-pharma" ;
  schema:name "Delta-Fly Pharma"@en ;
  schema:alternateName "Delta-Fly Pharma, Inc."@en, "デルタフライファーマ"@en ;
  schema:description "Delta-Fly is a small Japanese company from Tokushima that improves existing chemotherapy drugs; its continuous-infusion cytarabine analogue DFP-10917 is in phase 3 for relapsed acute myeloid leukaemia."@en ;
  schema:url <https://onco.cc/companies/delta-fly-pharma/>, <https://www.delta-flypharma.co.jp> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.delta-flypharma.co.jp>, <https://clinicaltrials.gov/search?lead=Delta-Fly%20Pharma%2C%20Inc.>, <https://www.wikidata.org/wiki/Q60997589> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "JP" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/nsclc/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> ;
  onco:trials <https://onco.cc/trials/nct06382168/> .